Company Filing History:
Years Active: 2013-2014
Title: Alain Thibault: Innovator in Cancer Treatment
Introduction
Alain Thibault is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of 2 patents, Thibault is recognized for his work in developing therapies that enhance the efficacy of cancer treatments.
Latest Patents
Thibault's latest patents focus on a method of treating cancer with DLL4 antagonists and chemotherapeutic agents. The invention provides methods for treating various types of cancer and tumors by administering a combination of DLL4 antagonists, particularly DLL4 antibodies and fragments that specifically bind to human DLL4, along with chemotherapeutic agents. These combination therapies exhibit synergistic effects compared to treatments with either agent alone. This approach is particularly beneficial for cancer patients who have low tolerance to the side effects caused by high dosages required for treatment with either agent alone, as it allows for reduced effective dosages. Additionally, pharmaceutical compositions and kits containing DLL4 antagonists and chemotherapeutic agents are also provided.
Career Highlights
Thibault is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to advance his research in cancer therapies. His work has been instrumental in developing innovative solutions that address critical challenges in cancer treatment.
Collaborations
Some of Thibault's coworkers include Irene Noguera-Troise and Gavin Thurston, who contribute to the collaborative efforts in research and development at Regeneron Pharmaceuticals.
Conclusion
Alain Thibault's contributions to cancer treatment through his innovative patents and research highlight his commitment to improving patient outcomes. His work exemplifies the importance of collaboration and innovation in the medical field.